结膜下 aflibercept 可抑制角膜血管生成和 VEGFR-3+CD11b+ 细胞。

IF 2.4 3区 医学 Q2 OPHTHALMOLOGY
Chang Ho Yoon, Jung Hwa Ko, Hyun Ju Lee, Hyun Beom Song, Joo Youn Oh
{"title":"结膜下 aflibercept 可抑制角膜血管生成和 VEGFR-3+CD11b+ 细胞。","authors":"Chang Ho Yoon, Jung Hwa Ko, Hyun Ju Lee, Hyun Beom Song, Joo Youn Oh","doi":"10.1007/s00417-024-06560-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to investigate the effects of subconjunctival injection of aflibercept, a soluble protein decoy for VEGFR-1 and VEGFR-2, on corneal angiogenesis and VEGFR-expressing CD11b<sup>+</sup> cells in a mouse model of suture-induced corneal neovascularization.</p><p><strong>Methods: </strong>Corneal neovascularization was induced in BALB/c mice by placing three sutures on the cornea. Immediately after surgery, either 200 µg aflibercept (5 µL) or an equal volume of phosphate-buffered saline (PBS) was administered into the subconjunctival space. Seven days after later, corneal new vessels were quantified through clinical examination and measurement of the CD31-stained area in corneal flat mounts. The levels of pro-angiogenic and inflammatory markers in the cornea were evaluated using RT-qPCR. The percentages of VEGFR-2<sup>+</sup>CD11b<sup>+</sup> cells and VEGFR-3<sup>+</sup>CD11b<sup>+</sup> cells were analyzed in the cornea, blood, and draining cervical lymph nodes (DLNs) using flow cytometry.</p><p><strong>Results: </strong>Subconjunctival injection of aflibercept significantly reduced the growth of corneal new vessels compared to subconjunctival PBS injection. The mRNA levels of Cd31, vascular growth factors (Vegfc and Angpt1), and pro-angiogenic/inflammatory markers (Tek/Tie2, Mrc1, Mrc2, and Il6) in the cornea were downregulated by subconjunctival aflibercept. Also, the percentage of VEGFR-3<sup>+</sup>CD11b<sup>+</sup> cells in the cornea, blood, and DLNs was decreased by aflibercept, whereas that of VEGFR-2<sup>+</sup>CD11b<sup>+</sup> cells was unaffected.</p><p><strong>Conclusion: </strong>Subconjunctival aflibercept administration inhibits inflammatory angiogenesis in the cornea and reduces the numbers of cornea-infiltrating and circulating VEGFR-3<sup>+</sup>CD11b<sup>+</sup> cells.</p>","PeriodicalId":12795,"journal":{"name":"Graefe’s Archive for Clinical and Experimental Ophthalmology","volume":" ","pages":"3881-3888"},"PeriodicalIF":2.4000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11608285/pdf/","citationCount":"0","resultStr":"{\"title\":\"Subconjunctival aflibercept inhibits corneal angiogenesis and VEGFR-3<sup>+</sup>CD11b<sup>+</sup> cells.\",\"authors\":\"Chang Ho Yoon, Jung Hwa Ko, Hyun Ju Lee, Hyun Beom Song, Joo Youn Oh\",\"doi\":\"10.1007/s00417-024-06560-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>This study aimed to investigate the effects of subconjunctival injection of aflibercept, a soluble protein decoy for VEGFR-1 and VEGFR-2, on corneal angiogenesis and VEGFR-expressing CD11b<sup>+</sup> cells in a mouse model of suture-induced corneal neovascularization.</p><p><strong>Methods: </strong>Corneal neovascularization was induced in BALB/c mice by placing three sutures on the cornea. Immediately after surgery, either 200 µg aflibercept (5 µL) or an equal volume of phosphate-buffered saline (PBS) was administered into the subconjunctival space. Seven days after later, corneal new vessels were quantified through clinical examination and measurement of the CD31-stained area in corneal flat mounts. The levels of pro-angiogenic and inflammatory markers in the cornea were evaluated using RT-qPCR. The percentages of VEGFR-2<sup>+</sup>CD11b<sup>+</sup> cells and VEGFR-3<sup>+</sup>CD11b<sup>+</sup> cells were analyzed in the cornea, blood, and draining cervical lymph nodes (DLNs) using flow cytometry.</p><p><strong>Results: </strong>Subconjunctival injection of aflibercept significantly reduced the growth of corneal new vessels compared to subconjunctival PBS injection. The mRNA levels of Cd31, vascular growth factors (Vegfc and Angpt1), and pro-angiogenic/inflammatory markers (Tek/Tie2, Mrc1, Mrc2, and Il6) in the cornea were downregulated by subconjunctival aflibercept. Also, the percentage of VEGFR-3<sup>+</sup>CD11b<sup>+</sup> cells in the cornea, blood, and DLNs was decreased by aflibercept, whereas that of VEGFR-2<sup>+</sup>CD11b<sup>+</sup> cells was unaffected.</p><p><strong>Conclusion: </strong>Subconjunctival aflibercept administration inhibits inflammatory angiogenesis in the cornea and reduces the numbers of cornea-infiltrating and circulating VEGFR-3<sup>+</sup>CD11b<sup>+</sup> cells.</p>\",\"PeriodicalId\":12795,\"journal\":{\"name\":\"Graefe’s Archive for Clinical and Experimental Ophthalmology\",\"volume\":\" \",\"pages\":\"3881-3888\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11608285/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Graefe’s Archive for Clinical and Experimental Ophthalmology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00417-024-06560-4\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/7/9 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Graefe’s Archive for Clinical and Experimental Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00417-024-06560-4","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/9 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:本研究旨在探讨在缝线诱导的角膜新生血管小鼠模型中,结膜下注射阿弗利百普(一种VEGFR-1和VEGFR-2的可溶性蛋白诱饵)对角膜血管生成和VEGFR表达的CD11b+细胞的影响:在 BALB/c 小鼠角膜上缝合三针,诱导角膜新生血管。术后立即在结膜下间隙注射 200 µg aflibercept(5 µL)或等体积的磷酸盐缓冲盐水(PBS)。七天后,通过临床检查和测量角膜平片上的 CD31 染色面积,对角膜新生血管进行量化。使用 RT-qPCR 评估了角膜中促血管生成和炎症标志物的水平。使用流式细胞术分析了角膜、血液和引流颈淋巴结(DLNs)中 VEGFR-2+CD11b+ 细胞和 VEGFR-3+CD11b+ 细胞的百分比:结果:与结膜下注射 PBS 相比,结膜下注射 aflibercept 能明显减少角膜新生血管的生长。结膜下注射 aflibercept 下调了角膜中 Cd31、血管生长因子(Vegfc 和 Angpt1)和促血管生成/炎症标志物(Tek/Tie2、Mrc1、Mrc2 和 Il6)的 mRNA 水平。此外,aflibercept 还降低了角膜、血液和 DLN 中 VEGFR-3+CD11b+ 细胞的比例,而 VEGFR-2+CD11b+ 细胞的比例则不受影响:结论:结膜下注射阿弗利百普能抑制角膜炎性血管生成,减少角膜浸润和循环中的 VEGFR-3+CD11b+ 细胞数量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Subconjunctival aflibercept inhibits corneal angiogenesis and VEGFR-3<sup>+</sup>CD11b<sup>+</sup> cells.

Subconjunctival aflibercept inhibits corneal angiogenesis and VEGFR-3+CD11b+ cells.

Purpose: This study aimed to investigate the effects of subconjunctival injection of aflibercept, a soluble protein decoy for VEGFR-1 and VEGFR-2, on corneal angiogenesis and VEGFR-expressing CD11b+ cells in a mouse model of suture-induced corneal neovascularization.

Methods: Corneal neovascularization was induced in BALB/c mice by placing three sutures on the cornea. Immediately after surgery, either 200 µg aflibercept (5 µL) or an equal volume of phosphate-buffered saline (PBS) was administered into the subconjunctival space. Seven days after later, corneal new vessels were quantified through clinical examination and measurement of the CD31-stained area in corneal flat mounts. The levels of pro-angiogenic and inflammatory markers in the cornea were evaluated using RT-qPCR. The percentages of VEGFR-2+CD11b+ cells and VEGFR-3+CD11b+ cells were analyzed in the cornea, blood, and draining cervical lymph nodes (DLNs) using flow cytometry.

Results: Subconjunctival injection of aflibercept significantly reduced the growth of corneal new vessels compared to subconjunctival PBS injection. The mRNA levels of Cd31, vascular growth factors (Vegfc and Angpt1), and pro-angiogenic/inflammatory markers (Tek/Tie2, Mrc1, Mrc2, and Il6) in the cornea were downregulated by subconjunctival aflibercept. Also, the percentage of VEGFR-3+CD11b+ cells in the cornea, blood, and DLNs was decreased by aflibercept, whereas that of VEGFR-2+CD11b+ cells was unaffected.

Conclusion: Subconjunctival aflibercept administration inhibits inflammatory angiogenesis in the cornea and reduces the numbers of cornea-infiltrating and circulating VEGFR-3+CD11b+ cells.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.40
自引率
7.40%
发文量
398
审稿时长
3 months
期刊介绍: Graefe''s Archive for Clinical and Experimental Ophthalmology is a distinguished international journal that presents original clinical reports and clini-cally relevant experimental studies. Founded in 1854 by Albrecht von Graefe to serve as a source of useful clinical information and a stimulus for discussion, the journal has published articles by leading ophthalmologists and vision research scientists for more than a century. With peer review by an international Editorial Board and prompt English-language publication, Graefe''s Archive provides rapid dissemination of clinical and clinically related experimental information.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信